[Lipid lowering treatment of severe hypertriglyceridemia with acute pancreatitis caused by everolimus in a patient with a neuroendocrine tumor].
We present the case of a woman with an intestinal neuroendocrine tumor who developed two episodes of acute pancreatitis, secondary to severe hypertriglyceridemia caused by everolimus. After treatment with fibrates and omega-3, triglyceride levels returned to baseline, without developing new metabolic or digestive complications. Targeted levels of triglyceride for cancer patients treated with everolimus, should be below 500 or 300 mg/dL, depending on whether life expectancy is less or longer than one year, respectively.
PMID: 32242549 [PubMed - as supplied by publisher]
Source: Anales del Sistema Sanitario de Navarra - Category: General Medicine Authors: de Carlos Artajo J, Castro Unanua N, Muruzábal Huarte E, Vera García R, Irigaray Echarri A, Zubiría Gortázar J, Anda Apiñániz E Tags: An Sist Sanit Navar Source Type: research
More News: Brain | Cancer | Cancer & Oncology | General Medicine | Neurology | Omega 3 | Pancreatitis | Toxicology | Transplants